International Patent: GENETICALLY ENGINEERED T CELLS EXPRESSING A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND USES THEREOF FOR ALLOGENEIC CELL THERAPY

GENEVA, Aug. 31 -- JUNO THERAPEUTICS, INC. filed a patent application (US2025/028570) for “GENETICALLY ENGINEERED T CELLS EXPRESSING A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND USES THEREOF FOR ALLOGENEIC CELL THERAPY”. With publication no. WO/2025/235851, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....